Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263575 · ClinicalTrials.gov registry record · Phase 3
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
A Phase 3 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 139
- Enrollment target
NCT00263575 is a Phase 3 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 139 participants.
The verdict
NCT00263575, a Phase 3 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 139 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of EN3267 in treating breakthrough pain episodes in opioid cancer patients who are using stable doses of opioid medication.
Interventions
- DRUG EN3267
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00263575
The ClinicalTrials.gov registry entry for NCT00263575 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin Co., which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EN3267 is the first listed.
NCT00263575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00263575 about?
NCT00263575 is a clinical study titled "Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients". The purpose of this study is to evaluate the long-term safety and effectiveness of EN3267 in treating breakthrough pain episodes in opioid cancer patients who are using stable doses of opioid medication.
What is the current status of trial NCT00263575?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 139 participants. The study started on 2005-12. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00263575?
The interventions under investigation include: EN3267 (DRUG).
Who is sponsoring clinical trial NCT00263575?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.